Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Iron in Heart Failure with Iron Deficiency
NCT04225728Phase 4Completed
- Start
- Dec 2017
- Primary completion
- Jun 2018
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) and heart failure (HF) comparing Iron sucrose IV, Ferric polymaltose IM and Placebo (3 arms). Primary endpoint: Variation in 6-minute walk test distance at 4 weeks. Started Dec 2017; status: completed.
02
Drugs
iron sucroseiron polymaltose
03
Conditions
iron deficiency anemia (IDA)heart failure (HF)
Beyond the preview
Go deeper on NCT04225728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04225728.